Atria Investments Inc Has $6.41 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Atria Investments Inc reduced its stake in CME Group Inc. (NASDAQ:CME) by 13.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,050 shares of the financial services provider’s stock after selling 4,370 shares during the quarter. Atria Investments Inc’s holdings in CME Group were worth $6,410,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Y.D. More Investments Ltd bought a new position in shares of CME Group in the 2nd quarter worth about $36,000. Thurston Springer Miller Herd & Titak Inc. grew its stake in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares during the period. McClarren Financial Advisors Inc. increased its holdings in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC lifted its stake in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after buying an additional 170 shares during the period. Finally, New Covenant Trust Company N.A. bought a new position in shares of CME Group during the 1st quarter worth approximately $82,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Up 0.1 %

CME Group stock opened at $225.93 on Tuesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $81.36 billion, a PE ratio of 23.76, a price-to-earnings-growth ratio of 5.68 and a beta of 0.55. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The firm’s 50-day simple moving average is $221.72 and its 200 day simple moving average is $209.84.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.25 earnings per share. Research analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

Wall Street Analyst Weigh In

CME has been the topic of a number of research reports. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. The Goldman Sachs Group increased their price objective on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Morgan Stanley boosted their target price on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. JPMorgan Chase & Co. increased their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Finally, Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $224.47.

Insider Activity at CME Group

In other news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.